Zomedica Corp (ZOM) Stock Plunges Below 50 Cents: Time To Panic?
On Wednesday, Zomedica Corp (NYSEAMERICAN:ZOM) announced its financial results for the second fiscal quarter but it seems that the market is not impressed by its performance and the stock has already declined by as much as 13% during the premarket trading period to $0.49. The veterinary health firm, which is known for its point of care diagnostics solutions for pets, suffered a loss of $4.6 million during the quarter, which…